Market closed

Sanofi/€SAN

07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX

About Sanofi

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 20% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

Ticker

€SAN

Trading on

PAR

Industry

Pharmaceuticals
Headquarters

Employees

82,878

Sanofi Metrics

BasicAdvanced
€127B
23.23
€4.44
0.46
€3.76
3.80%
€127B
0.46
€110.88
€85.07
2.2M
€3.76
1.46
0.28
17.216
22.944
84.60%
8.45%
4.37%
7.53%
23.229
2.915
1.67
6.53
21.932
3.64%
3.80%
-3.80%
6.75%
4.17%
-2.49%
5.59%

What the Analysts think about Sanofi

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Sanofi stock.

Sanofi Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Sanofi Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe

Buy €SAN

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

May12
Sanofi
Dividend·Ex-dividend
May14
Sanofi
Dividend·Payment
€3.92
Per share
FAQs

What’s the current market cap for Sanofi stock?

Sanofi (SAN) has a market cap of €127B as of March 31, 2025.

What is the P/E ratio for Sanofi stock?

The price to earnings (P/E) ratio for Sanofi (SAN) stock is 23.23 as of March 31, 2025.

Does Sanofi stock pay dividends?

Yes, the Sanofi (SAN) stock pays dividends to shareholders. As of March 31, 2025, the dividend rate is €3.76 and the yield is 3.8%. Sanofi has a payout ratio of 84.6% on a trailing twelve-month basis.

When is the next Sanofi dividend payment date?

The next Sanofi (SAN) dividend payment is scheduled for May 14, 2025.

What is the beta indicator for Sanofi?

Sanofi (SAN) has a beta rating of 0.46. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.